Trading Secrets: An Unwise Move In The Electronic Age

Law360, New York (April 12, 2012, 2:26 PM EDT) -- In the ongoing battle between competitors in the aesthetics field, the court in Allergan Inc. v. Merz Pharmaceuticals LLC, et al. recently completed a nine-day bench trial resulting in an injunction against the defendants to prevent the actual or threatened misappropriation of plaintiff Allergan Inc.’s trade secrets.

Allergan produces several different prescription medicines, including Botox Cosmetics and Juvederm, which are injectable treatments used to correct facial wrinkles and folds. Merz Aesthetics Inc. also had for years been in the facial aesthetics market, and had a product...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.